Combination therapy w/ ACTOS (pioglitazone HCI) shown to improve components of diabetic dyslipidemia Part 2Category: Uncategorized | Leave a Comment |
7 12 2008 |
Three randomized, double-blind, multi-center trial studied the effect of ACTOS 30 mg or 45 mg plus any a sulfonylurea, metformin or insulin via the squad of HDL and LDL plane and subclass piece proportions profile delimited by patients next to nature 2 diabetes done a 24-week length. More than 250 patients in the […]
Depression And Diabetes: Fellow Travelers, Researchers Say Part 2Category: Uncategorized | Leave a Comment |
4 12 2008 |
Hughes AM, Lightfoot T, Simpson J, Ansell P, McKinney PA , Kinsey SE, Mitchell CD, Eden TOB, Greaves M, Roman E on behalf of the United Kingdom Childhood Cancer Study Investigators.International Journal of Cancer 2007; 121: 819-824 Cancer Research Summaries are overview of high-status cancer research findings that have be report in prevailing […]
Two Merck Medicines Recommended For Approval In The European Union Part 3Category: Uncategorized | Leave a Comment |
3 12 2008 |
In clinical inspection, the maximum widespread adverse reaction inspection, regardless of investigator estimate of causality, surrounded by >5 percent of patients and more readily than in patients treat near placebo be in set down of haunt: diarrhea, upper respiratory tract infectivity and headache (for sitagliptin and metformin concoction therapy); nasopharyngitis (for sitagliptin monotherapy); […]